Hca Stock Quote: Financial Performance and Strength

HCA stock quote has consistently shown impressive financial performance over the years. The company's strong revenue growth is a testament to its expanding network of healthcare facilities.

HCA Healthcare's net income has consistently exceeded $2 billion annually since 2015. This is a remarkable feat, especially considering the company's diverse range of healthcare services.

The company's ability to adapt to changing market conditions has been a key factor in its success. By expanding into new markets and investing in cutting-edge technology, HCA has been able to stay ahead of the competition.

HCA's strong balance sheet has also been a major contributor to its financial success. The company's low debt-to-equity ratio and high cash reserves have provided a solid foundation for future growth.

HCA Healthcare's revenue in 2024 was a whopping $70.60 billion, an 8.67% increase from the previous year's $64.97 billion. This significant growth is a testament to the company's strong financial performance.

Their earnings also saw a notable increase, rising by 9.88% to $5.76 billion. This impressive growth in earnings is a clear indication of HCA Healthcare's ability to manage its finances effectively.

Here's a quick summary of their financial performance:

HCA Healthcare's financial strength is a crucial aspect of its overall financial performance. The company's cash-to-debt ratio is a mere 0.04, indicating a significant amount of debt.

HCA's debt-to-equity ratio is also concerning, with a negative value of -17.97. This suggests that the company's debt exceeds its equity. In contrast, its interest coverage ratio is 5.12, indicating that the company's earnings can cover its interest payments.

HCA's Piotroski F-Score is 8/9, which is a good sign, indicating that the company's financial health is relatively strong. On the other hand, its Altman Z-Score is 2.65, which falls into the "Distress" category, suggesting that the company is at risk of financial distress.

Here's a summary of HCA's key financial strength metrics:

These metrics suggest that HCA Healthcare's financial strength is a mixed bag, with some positive signs and some concerning indicators.

HCA Healthcare's shareholder returns have been impressive, with a 9.0% return over the past year.

In comparison to the US Healthcare industry, HCA's returns were significantly higher, outperforming the sector by 7.0% over the past year.

Here's a breakdown of HCA's shareholder returns compared to the US Healthcare industry and the US Market:

HCA's 9.0% return over the past year is a testament to the company's financial performance, which has been consistently strong.

HCA's revenue reached $70.60 billion in 2024, a significant increase of 8.67% from the previous year. This growth is a testament to the company's strong financial performance.

Their earnings also saw a substantial boost, rising by 9.88% to $5.76 billion. This impressive growth demonstrates the company's ability to generate substantial profits.

In terms of share price, HCA's current price is $328.70, with a 52-week high of $417.14 and a low of $289.98. This means that the stock has experienced some volatility over the past year.

Here's a quick snapshot of HCA's share price performance over the past year:

HCA's beta is 1.65, indicating that the stock is more volatile than the overall market. However, the company's average weekly movement of 3.7% is relatively stable compared to the healthcare industry's average movement of 8.1%.

Investors are worried about healthcare stocks, especially hospital operators, following a Trump administration win.

Some exceptions to this trend include Medicare Advantage plan providers, who are optimistic about their fate.

Recent hurricanes have hurt hospital operator HCA Healthcare's results and outlook, causing its stock to slump about 10% on one occasion.

The negative impact of hurricanes on HCA's results is expected to continue, with the company anticipating a 60-90 cent hit to fourth-quarter earnings.

Despite this, HCA's stock has also had moments of strength, such as when it beat consensus for both EPS and Revenue in its Q4 and Full-Year FY24 earnings.

HCA's strong core business and industry tailwinds have contributed to its success, driving greater growth and acceleration.

HCA Healthcare's stock has seen significant growth over the years, with a 5-year change of 127.68% since its IPO.

The company's current share price is $328.70, which is a 1-month change of 8.65% and a 1-year change of 8.99%.

HCA Healthcare's stock has also experienced a 3-year change of 38.50%, indicating steady growth over time.

Here's a breakdown of the company's share price history and performance:

HCA's price has been relatively stable in the past 3 months, with an average weekly movement of 3.7%, compared to the US market's average movement of 6.5%.

The company's price volatility has actually decreased over the past year, with a weekly volatility of 4% that has remained stable.

HCA's beta, a measure of its stock's volatility compared to the overall market, is 1.65, indicating that its price movements are more volatile than the market average.

Here's a comparison of HCA's price movement with the healthcare industry and the market:

HCA's price has also seen significant growth over the long term, with a 5-year change of 127.68% and a change since IPO of 959.64%.